POC NAME | MEASURED PARAMETERS | TEST TIME | IMPRECISION | ACCURACY |
---|---|---|---|---|
Carestart™ (Access Bio, Somerset, USA) [344-346] | G-6-PDH activity | 10 minutes | N/A | r = 0.73 |
G6PD Assay (Trinity Biotech, St. Louis, USA) [344, 347] | G-6-PDH activity | < 70 minutes | CV = 4.5% | r = 0.98 |
Sickle SCAN™ test (BioMedomics, Inc., Durham, USA) [348-351] | HbA, HbS, HbC | 2 minutes | N/A | r = 0.99 |
Q3 portable real-time PCR instrument (Thermo Fisher Scientific, Waltham, USA) [352] | ABCB1 3435, CYP2C19*2 and CYPC2C19*17 polymorphisms |
30 minutes | N/A | r = 1.00 |
GeneXpert® (Cepheid, Sunnyvale, USA) [353] | BCR-ABL gene fusion in leukemia cells | 150 minutes | CV = 41.35% | r = 0.99 |
Verigene CYP2C19 Nucleic Acid Test (Nanosphere Inc, Northbrook, USA) [354, 355] | CYP2C19 polymorphisms | 210 minutes | N/A | r = 1.00 |
RX CYP2C19 System (Spartan Bioscience Inc., Ottawa, Canada) [355, 356] | CYP2C19 polymorphisms | < 60 minutes | N/A | r = 1.00 |